Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bovine Lactoferrin for the Prevention of COVID-19 Infection in Physicians and Nurses in Hospitals in Lima, Peru: a Double Blinded Randomized Clinical Trial (LF-COVID)

NCT04526821 is registered in ClinicalTrials.gov with Universidad Peruana Cayetano Heredia as lead sponsor.

NCT NCT04526821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04526821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bovine Lactoferrin for the Prevention of COVID-19 Infection in Physicians and Nurses in Hospitals in Lima, Peru: a Double Blinded Randomized Clinical Trial (LF-COVID)
Lead sponsor
Universidad Peruana Cayetano Heredia
Phase
Phase 2
Overall status
Terminated
Start date
October 17, 2020
Completion date
February 10, 2021
Enrollment
209 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2